Showing results (101-110 of 133) with videos related to
Sort By:
Pageof 14
Journal of Surgical Oncology|July 7, 2012
Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtypeCary Hsu, Asif Rashid, Yan Xing, et al.Annals of Surgical Oncology|September 27, 2025
Repeat Cytoreductive Surgery for Colorectal Cancer Metastatic to the Peritoneal CavityPaula Marincola Smith, Jessica J Lie, Ashlee Seldomridge, et al.Biorxiv : the Preprint Server for Biology|March 30, 2023
Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinomaIchiaki Ito, Abdelrahman Mg Yousef, Princess N Dickson, et al.Annals of Surgical Oncology|January 14, 2015
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial NeoplasmsJ H Choe, M J Overman, K F Fournier, et al.Journal of Virology|October 15, 2003
Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cellsRajas V Warke, Kris Xhaja, Katherine J Martin, et al.Annals of Surgical Oncology|February 1, 2018
Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 TrialAndrea A Hayes-Jordan, Brian A Coakley, Holly L Green, et al.Annals of Surgical Oncology|March 21, 2022
What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers?Abhineet Uppal, Beth Helmink, Travis E Grotz, et al.The American Journal of Surgical Pathology|August 10, 2020
Malignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 CasesAnais Malpica, Elizabeth D Euscher, Mario L Marques-Piubelli, et al.Cancer Research|July 11, 2023
Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal AdenocarcinomaIchiaki Ito, Abdelrahman M G Yousef, Saikat Chowdhury, et al.Annals of Surgical Oncology|July 12, 2017
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient SelectionTravis E Grotz, Michael J Overman, Cathy Eng, et al.Pageof 14